- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 7.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 6.42M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $766 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$192.54K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$555.33K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.46M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.09M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.01M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.62M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.53M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.28M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.45M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.97M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.21M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.57M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $672.2K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $664.24K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$626.2K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$565.13K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $47.29K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $147.59K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $16.91K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $147.6K |